The NECTA Drug Development Meeting 2026 will be held on Friday, 27 March 2026, at the Garvan Institute of Medical Research in Sydney.

This specialized forum focuses on critical shifts in early-phase oncology, including the reformation of dose optimization and the challenges of agnostic precision oncology for unknown targets. The agenda also highlights novel clinical trial insights from the Asian market and a dedicated focus on the wellbeing of clinical coordinators and clinicians. Attendance is available both in-person at the Darlinghurst auditorium and online, with the meeting offering free registration for academic and clinical professionals.

Register.